Cholera toxin increases intracellular pH in B lymphoma cells and decreases their antigen-presenting ability

European Journal of Immunology

Volumn 29, Issue 5, 1999, Pages 1561-1570

  Tanaka, Yuriko ^a,b   Nakano, Hideki ^a   Ishikawa, Fumio ^a   Yoshida, Mitsutaka ^b   Gyotoku, Yuichi ^c   Kakiuchi, Terutaka ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c AJINOMOTO CO INC   (Japan)

Author keywords

Antigen presentation; B lymphocyte; Cholera toxin; Intracellular pH

Indexed keywords

2',3' DIDEOXYADENOSINE; ADJUVANT; B7 ANTIGEN; CD86 ANTIGEN; CHOLERA TOXIN; CYCLIC AMP; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; B CELL LYMPHOMA; CELL PH; CONTROLLED STUDY; ENDOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; CHICKENS; CHOLERA TOXIN; HYDROGEN-ION CONCENTRATION; INTRACELLULAR FLUID; LYMPHOMA, B-CELL; MICE; OVALBUMIN; TUMOR CELLS, CULTURED;

EID: 0032955367     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199905)29:05<1561::AID-IMMU1561>3.0.CO;2-Z     Document Type: Article

References (44)

1. Lycke, N. and Holmgren, J., Strong adjuvant properties of cholera toxin in gut mucosal immune response to orally presented antigens. Immunology 1986. 59: 301-308.
2. McKenzie, S. J. and Halsey, J. F., Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J. Immunol. 1984. 133: 1818-1824.
3. Czerkinsky, C., Russell, M. W., Lycke, N., Lindblad, M. and Holmgren, J., Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody response in salivary glands and extramucosal tissues. Infect. Immun. 1989. 57: 1072-1077.
4. Wu, H.-Y. and Russell, M. W., Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 1993. 61: 314-322.
5. Tamura, S., Yamanaka, A., Shimohara, M., Tomita, T., Komase, K., Tsuda, Y., Suzuki, Y., Nagamine, T., Kawahara, K., Donbara, H., Aizawa, C., Oya, A. and Kurata, T., Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994. 12: 419-426.
6. Liang, X., Lamm, M. E. and Nedrud, J. G., Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J. Immunol. 1988. 141: 1495-1501.
7. Lycke, N., Tsuji, T. and Holmgren, J., The adjuvant effect of Vibrio cholerae and E. coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 1992. 22: 2277-2281.
8. Vajdy, M. and Lycke, N. Y., Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization. Immunology 1992. 74: 488-492.
9. Bromander, A. K., Kjerrulf, M., Holmgren, J. and Lycke, N., Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. Scand. J. Immunol. 1993. 37: 452-458.
10. Anastassiou, E. D., Yamada, H., Francis, M. L., Mond, J. J. and Tsokos, G. C., Effect of cholera toxin on human B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-μ antibody-induced cell proliferation. J. Immunol. 1990. 145: 2375-2380.
11. Bromander, A., Holmgren, J. and Lycke, N., Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 1991. 146: 2908-2914.
12. Papadimitriou, E., Mintzas, S., Skoutari, M., Dimitracopoulos, G. and Anastassiou, E. D., Cholera toxin stimulates human B cell DR antigen biosynthesis at the revel of translation. Cell. Immunol. 1997. 180: 176-184.
13. Francis, M. L., Ryan, J., Jobling, M. G., Holmes, R. K., Moss, J. and Mond, J. J., Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation. J. Immunol. 1992. 148: 1999-2005.
14. Hirabayashi, Y., Tamura, S., Shimada, K. and Kurata, T., Involvement of antigen-presenting cells in the enhancement of the in vivo antibody responses by cholera toxin B subunit. Immunology 1992. 75: 493-498.
15. Li, T.-K. and Fox, B. S., Cholera toxin B subunit binding to an antigen-presenting cell directly costimulates cytokine production from T cell clone. Int. Immunol. 1996. 8: 1849-1856.
16. Figueiredo, F., Uhing, R. J., Okonogi, K., Gettys, T. W., Johnson, S. P., Adams, D. O. and Prpic, V., Activation of the cAMP cascade inhibits an early event involved in murine macrophage la expression. J. Biol. Chem. 1990. 265: 12317-12323.
17. Matousek, M. P., Nedrud, J. G. and Harding, C. V., Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages. J. Immunol. 1996. 156: 4137-4145.
18. Kakiuchi, T., Watanabe, M., Hozumi, N. and Nariuchi, H., Differential sensitivity of specific and nonspecific antigen-presentation by B cells to a protein synthesis inhibitor. J. Immunol. 1990. 145: 1653-1658.
19. Diment, S., Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. J. Immunol. 1990. 145: 417-422.
20. Rodriguez, G. M. and Diment, S., Role of cathepsin D in antigen presentation of ovalbumin. J. Immunol. 1992. 149: 2894-2898.
21. Mizuochi, T., Yee, S.-T., Kasai, M., Kakiuchi, T., Muno, D. and Kominami, E., Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain. Immunol. Lett. 1994. 43: 189-193.
22. Michalek, M. T., Benacerraf, B. and Rock, K. L., Weak base amines can inhibit class I MHC-restricted antigen presentation. J. Immunol. 1991. 146: 449-456.
23. Greenbaum, L. M., Cathepsins and kinin-forming and -destroying enzymes. In Boyer, P. D., (Eds.) The enzymes. Academic Press, New York 1971. p. 476-478.
24. Riese, R. J., Wolf, P. R., Bromme, D., Natkin, L. R., Villadangos, J. A., Ploegh, H. L. and Chapman, H. A., Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996. 4: 357-366.
25. Kokuho, T., Nariuchi, H., Gyotoku, Y. and Kakiuchi, T., Role of newly synthesized MHC class II molecules in antigen-specific antigen presentation by B cells. Immunobiology 1995. 193: 42-58.
26. Wettstein, D. A., Boniface, J. J., Reay, P. A., Schild, H. and Davis, M. M., Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J. Exp. Med. 1991. 174: 219-228.
27. Harding, C. V., Roof, R. W., Allen, P. M. and Unanue, E. R., Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 1991. 88: 2740-2744.
28. Van Dyke, R. W., Cholera toxin and pertussis toxin increase acidification of endocytic vesicles without altering ion conductance. Am. J. Physiol. 1997. 272: C1123-1133.
29. Cong, Y., Weaver, C. T. and Elson, C. O., The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7-2 expression. J. Immunol. 1997. 159: 5301-5308.
30. Marinaro, M., Staats, H. F., Hiroi, H., Jackson, R. J., Coste, M., Boyaka, P. N., Okahayashi, N., Yamamoto, M., Kiyono, H., Bluethmann, H., Fujihashi, K. and McGhee, J. R., Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 1995. 155: 4621-4629.
31. Sun, J.-B., Holmgren, J. and Czerkinsky, C., Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 1994. 91: 10795-10799.
32. Snider, D. P., Marshall, J. S., Perdue, M. H. and Liang, H., Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J. Immunol. 1994. 153: 647-657.
33. Wilson, A. D., Clarke, C. J. and Stokes, C. R., Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scand. J. Immunol. 1990. 31: 443-451.
34. Eisen, H. N., Preparation of immunogenic 2,4-dinitrophenyl and 2,4,6-trinitrophenyl proteins. In Williams, C. A. and Chase, M. W., (Eds.) Methods in immunology and immunocytochemistry, Vol. 1. Academic Press, New York 1967, pp. 128-133.
35. Bhattacharya, A., Dorf, M. E. and Springer, T. A., A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J. Immunol. 1981. 127: 2488-2495.
36. Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P. and Modes, R.J., Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 1993. 262: 905-907.
37. Sarmiento, M., Dialynas, D. P., Lancki, D. W., Wall, K. A., Lorber, M. I., Loken, M. R. and Fitch, F. W., Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol. Rev. 1982. 68: 135-169.
38. Dialynas, D. P., Quan, Z. S., Wall, K. A., Pierres, A., Quintans, J., Loken, M. R., Pierres, M. and Fitch, F. W., Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human leu-3/T4 molecule. J. Immunol. 1983. 131: 2445-2451.
39. Takei, F., Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J. Immunol. 1985. 134: 1403-1407.
40. Powers, G. D., Faherty, D. A., Connaughton, S. E., Biondi, D. A., Godfrey, D. A., Gault, A., Chen, C.-Y. and Nabavi, N., Expression and functional analysis of murine B7 delineated by a novel monoclonal antibody. Cell. Immunol. 1994. 153: 298-311.
41. Holmes, K. and Fowlkes, B. J., Preparation of cells and reagents for flow cytometry. In Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M. and Strober, W. (Eds.) Current protocols in immunology. Wiley, New York 1995, pp. 5.3.5-5.3.6.
42. Watanabe, M., Wegmann, D. R., Ochi, A. and Hozumi, N., Antigen presentation by a B-cell line transfected with cloned immunoglobulin heavy- and light-chain genes specific for a defined hapten. Proc. Natl. Acad. Sci. USA 1986. 83: 5247-5251.
43. Lindner, R. and Unanue, E. R., Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 1996. 15: 6910-6920.
44. Gosselin, E. J., Tony, H. P. and Parker, D., Characterization of antigen processing and presentation by B lymphocytes. J. Immunol. 1988. 140: 1408-1413.